Cargando…
Identifying Outcome Measures for Coronary Artery Disease Value-Based Contracting Using the Delphi Method
INTRODUCTION: Value-based contracts (VBCs) that link drug payments to disease-related performance metrics aim to increase the value and lower the cost of medications by aligning incentives and sharing risk between payers and pharmaceutical manufacturers. This study sought to identify outcome measure...
Autores principales: | Neilson, Lynn M., Swart, Elizabeth C. S., Good, Chester B., Shrank, William H., Henderson, Rochelle, Manolis, Chronis, Parekh, Natasha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525225/ https://www.ncbi.nlm.nih.gov/pubmed/30825093 http://dx.doi.org/10.1007/s40119-019-0132-7 |
Ejemplares similares
-
Using the Delphi method to identify meaningful and feasible outcomes for pharmaceutical value-based contracting
por: Swart, Elizabeth C S, et al.
Publicado: (2020) -
Effect of Carving in Pharmacy Benefits on Utilization and Costs
por: Parekh, Natasha, et al.
Publicado: (2020) -
Twelve month oral contraceptive pill prescriptions: Role of policy mandates on utilization
por: Peasah, Samuel K., et al.
Publicado: (2021) -
Health care utilization and costs associated with switching from DPP-4i to GLP-1RA or SGLT2i: an observational cohort study
por: Newman, Terri Victoria, et al.
Publicado: (2021) -
Examining Misaligned Incentives for Payers and Manufacturers in Value-Based Pharmaceutical Contracts
por: Kannarkat, Joseph T., et al.
Publicado: (2020)